Published in Int J Cancer on August 01, 2006
Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res (2009) 1.04
Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol Appl Pharmacol (2010) 0.95
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer (2009) 0.95
Isoflavones - Mechanism of Action and Impact on Breast Cancer Risk. Breast Care (Basel) (2009) 0.94
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Res (2014) 0.92
Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol (2008) 0.88
Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer. Am J Pathol (2010) 0.84
Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro. Oncotarget (2016) 0.79
Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells. Oncogene (2014) 0.76
Dietary Isoflavones and Breast Cancer Risk. Medicines (Basel) (2017) 0.75
Choosing the right cell line for breast cancer research. Breast Cancer Res (2011) 3.57
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. J Clin Oncol (2008) 3.23
Breast cancer cell lines: friend or foe? Breast Cancer Res (2003) 1.98
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res (2012) 1.97
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Breast Cancer Res Treat (2009) 1.73
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res (2008) 1.58
The rising incidence of male breast cancer. Breast Cancer Res Treat (2008) 1.54
Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol (2003) 1.43
Male breast carcinoma: increased awareness needed. Breast Cancer Res (2011) 1.40
Estrogen receptor regulation: don't forget translation. Breast Cancer Res Treat (2010) 1.39
Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.38
Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol (2012) 1.13
Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. Cancer Res (2010) 1.12
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat (2011) 1.12
Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res (2004) 1.07
MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion. J Pathol (2013) 1.07
Steroid hormone receptor expression in breast cancer stroma. Breast Cancer Res Treat (2014) 1.05
Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen. Clin Cancer Res (2008) 0.98
The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example. J Clin Pathol (2012) 0.97
Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol (2006) 0.97
A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer. Breast Cancer Res Treat (2007) 0.96
Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation. Breast Cancer Res Treat (2010) 0.94
The practicalities of using tissue slices as preclinical organotypic breast cancer models. J Clin Pathol (2012) 0.93
Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancer. J Cell Mol Med (2010) 0.92
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue. Breast Cancer Res Treat (2005) 0.92
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer. Hum Mol Genet (2002) 0.91
Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis. Biochim Biophys Acta (2013) 0.89
Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms. Biochem J (2010) 0.89
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer. Am J Pathol (2011) 0.88
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series. Breast Cancer Res Treat (2014) 0.85
Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer. Am J Pathol (2010) 0.84
Intracellular flow cytometric analysis of primary cultured breast tumor cells. Cancer Invest (2002) 0.84
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction. J Pathol (2011) 0.83
The evolving role of oestrogen receptor beta in clinical breast cancer. Breast Cancer Res (2008) 0.83
Identification of stage-specific breast markers using quantitative proteomics. J Proteome Res (2013) 0.82
Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts. Histopathology (2011) 0.82
Gene expression of ERbeta isoforms in laser microdissected human breast cancers: implications for gene expression analyses. Cell Oncol (2009) 0.80
Conditions of the male breast: Gynaecomastia and male breast cancer (Review). Mol Med Rep (2011) 0.79
External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer. J Clin Pathol (2013) 0.79
Clinical importance of estrogen receptor beta isoforms in breast cancer. J Clin Oncol (2008) 0.78
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer. Breast Cancer Res Treat (2014) 0.78
Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. Int J Oncol (2013) 0.77
Identification of differentially expressed genes in matched formalin-fixed paraffin-embedded primary and metastatic melanoma tumor pairs. Pigment Cell Melanoma Res (2012) 0.77
British Cancer Research Meeting, 30 June-3 July 2002, Glasgow. Breast Cancer Res (2002) 0.77
The potential utility of geminin as a predictive biomarker in breast cancer. Breast Cancer Res Treat (2013) 0.77
Estrogen receptor β: putting a positive into triple negative breast cancer? Horm Mol Biol Clin Investig (2013) 0.76
Investigating and critically appraising the expression and potential role of androgen receptor in breast carcinoma. Horm Mol Biol Clin Investig (2011) 0.76
PSMD9 expression predicts radiotherapy response in breast cancer. Mol Cancer (2014) 0.76
8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003. Breast Cancer Res (2004) 0.75
Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001. Clin Cancer Res (2003) 0.75
The estrogen receptors alpha, beta, and beta cx. Clin Cancer Res (2005) 0.75
Correspondence re: S. A. W. Fuqua et al., Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res.,63: 2434-2439, 2003. Cancer Res (2003) 0.75
Estrogen receptor beta--which one and where should we draw the line? Hum Pathol (2006) 0.75
Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient. Cell Tissue Bank (2014) 0.75
The value of archival tissue blocks in understanding breast cancer biology. J Clin Pathol (2013) 0.75